EXOZYMES INC. — Director's Dealing 2025

Jan 21, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Invizyne Technologies Inc (IZTC)
CIK: 0002010788
Period of Report: 2025-01-16

Reporting Person: Heltzen Michael (Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-01-16	Common Stock	P	121	$10.72	Acquired	2105	Direct
2025-01-17	Common Stock	P	1767	$10.78	Acquired	3872	Direct

Footnotes

F1: The reported price in Column 4 is a weighted average purchase price. The shares acquired on January 17, 2025 were purchased in multiple transactions at prices ranging from $10.45 to $11.00 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.